Gait Changes in Breast Cancer Patients Receiving Chemotherapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study measures gait parameters in women with breast cancer who are receiving chemotherapy, using objective gait data collected at baseline, 3 months, and 6 months after starting treatment. The goal is to understand how chemotherapy-related changes in muscle strength and balance influence gait. Findings could inform future rehabilitation strategies to improve mobility and daily functioning. No experimental treatment is given; the study relies on gait parameter assessments to characterize changes over time.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ranged from 40 to 50 years old.
* Female patients.
* Suffering from breast cancer, and receiving chemotherapy.
* Will be assessed before chemotherapy, 3 months and 6 months after chemotherapy.
* All enrolled patients will have signed their informed consent signed.

Exclusion Criteria:

* No history of prior chemotherapy.
* Current metastases.
* Orthopedic problems that affect balance and gait.
* Diabetic patients with neuritis.
* Peripheral neuropathy.
* Polyarthritis.

Where it's running

• National Cancer Institute
  Cairo, Cairo Governorate, Egypt Recruiting

Study contacts

• Principal investigator: Mostafa A Abdelhalim, B.Sc — Physical Therapist
• Study coordinator: Mustafa A Abdelhalim, B.Sc
• Email: adampt80a@gmail.com
• Phone: 01273902755

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• VR-guided mindfulness for anxiety, sleep, comfort, and fatigue in women with breast cancer undergoing chemotherapy

  This study tests whether a virtual reality–based mindfulness program can help women with breast cancer feel less anxious, sleep better, feel more comfortable, and have less fatigue during chemotherapy.

  Recruiting Hacettepe University · Ankara, Ankara · NCT07731477

• Electroacupuncture plus self-acupressure to improve quality of life during chemotherapy for early-stage breast cancer

  This trial tests whether adding electroacupuncture together with self-acupressure can improve quality of life for people with early-stage breast cancer who are receiving chemotherapy.

  Recruiting Affiliated Hospital of Qinghai University · Xining, Qinghai · NCT06601621

• Combining targeted therapies for solid tumors using CDK4/6 inhibitors and anti-VEGF agents

  This study is testing if combining two cancer treatments, Palbociclib and Bevacizumab, can help people with solid tumors like colorectal, breast, and ovarian cancers feel better and respond better to treatment.

  Recruiting at 2 sites Phase 1 Lebanese University · Tripoli, North Lebanon and 1 other locations · NCT06307249

• Comparing axillary radiotherapy and lymphadenectomy in breast cancer patients after neoadjuvant therapy

  This study is testing whether using axillary radiotherapy instead of surgery can help breast cancer patients who have had neoadjuvant treatment avoid lymphedema.

  Recruiting at 57 sites Hospital Universitari de Bellvitge · Sydney, New South Wales and 60 other locations · NCT04889924

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.